Aseptic meningitis associated with muromonab CD3 administration

Monoclonal antibodies for kidney allograft rejection. Med Lett Drug Ther 1986; 28: 97–8.

Ortho Multicenter Transplant Study Group. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Eng J Med 1985; 313: 337–42.

Thistlethwaite JR , Stuart JK , Mayes JT Monitoring and complications of monoclonal therapy: complications and monitoring of OKT3 therapy. Am J Kidney Dis 1988; 11: 112–9.

Tami JA , Parr MD , Brown SA , Thompson JS . Monoclonal antibody technology. Am J Hosp Pharm 1986; 43: 2816–25.

Canafax DM , Draxler CA . Monoclonal antilymphocyte antibody (OKT3) treatment of acute renal allograft rejection. Pharmacotherapy 1987; 7: 121–4.

Strom TB . Immunosuppressive agents in renal transplantation. Kidney Int 1984; 26: 353–65.

Roden J , Klintmalm GBG , Husberg BS , Nery J , Olson LM . Cerebrospinal fluid inflammation during OKT3 therapy (letter). Lancet 1987; 2: 272.

Dawson LJ , Amerson AB . OKT3 induced aseptic meningitis-report of a case. Presented at the 22nd Annual American Society of Hospital Pharmacists Midyear Clinical Meeting, December 7, 1987, Atlanta, GA.

Aseptic meningitis among kidney transplant recipients receiving a newly marketed murine monoclonal antibody preparation. MMWR 1986; 35: 551–2.

Neurological disorders. In: Davies DM , ed. Textbook of adverse drug reactions. New York: Oxford University Press, 1985; 494–514.

Emmons C , Smith J , Flanigan M. Cerebrospinal fluid inflammation during OKT3 therapy (letter). Lancet 1986; 2: 510–1.